Northwestern Medicine scientists and collaborators discovered that mutations in the TEK gene lead to primary congenital glaucoma, validating previous findings in mice and suggesting a target for future therapies.
Scientists at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University will test Guardant Health’s technology to detect cancer at early stages in high-risk populations.
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
Navdeep Chandel, PhD, David W. Cugell Professor of Medicine, has received the National Cancer Institute’s Outstanding Investigator Award to explore how mitochondrial metabolism plays a role in cancer.
Certain anatomical properties of the brain – not the initial injury – determine most of a patient’s risk of developing chronic pain, according to a new study.
The results of a recent study co-authored by C. David James, PhD, uncovered potential new targets for treating glioblastoma, a fatal brain tumor for which there is currently no cure.
Scientists have created a glowing map of the very first cells to be infected with an HIV-like virus, pinpointing the vulnerable points where HIV may enter the female reproductive tract.
A biodegradable nanoparticle can hide an allergen in a friendly shell to convince the immune system not to attack it, according to new Northwestern Medicine research.